Jacob Haynes, MD
Adult Reconstructive Orthopaedic Surgery · Oklahoma City, OKNPI 1629331921
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,687 of the $16,612 with a category attached, or 70.4%. Omnilife Science, Inc accounts for 87.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $6,731 and has fallen 96.3% since, to $251 in 2025.
Across 91 payments — averaging $182.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Omnilife Science, Inc$15K
- Stryker$1K
- Zimmer Biomet$143
- Medacta USA, Inc.$134
- Johnson & Johnson$60
- Radius Health, Inc.$45
- plus $165 from 7 others
What the payments were for
- Consulting fees$11,68770%
- Travel & lodging$2,35714%
- Food & beverage$2,56815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Omnilife Science, Inc | 31 | $14,602 |
| Stryker | 42 | $1,463 |
| Zimmer Biomet | 4 | $143 |
| Medacta USA, Inc. | 1 | $134 |
| Johnson & Johnson | 2 | $60 |
| Radius Health, Inc. | 3 | $45 |
| Si-bone, Inc. | 1 | $36 |
| Smith+Nephew | 2 | $34 |
| SPR Therapeutics, Inc | 1 | $31 |
| Vericel Corporation | 1 | $24 |
| Avanos Medical | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $15 |
| Aesculap Implant Systems, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNIBotics 3.0$8,301
- Corin Hips$5,187
- Corin Technology$575
- ADAPT$140
- GMK SPHERE$134
- ACCOLADE$129
How this compares
Too few adult reconstructive orthopaedic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 569 | $7,012 |
| Celecoxib | 74 | $2,441 |
| OxycontinOxycodone Hcl | 23 | $1,290 |
| Cyclobenzaprine Hcl | 165 | $1,187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $938 |
| Pregabalin | 62 | $746 |
| Tramadol Hcl | 192 | $662 |
| Cefadroxil | 44 | $382 |
| Gabapentin | 18 | $324 |
| Tizanidine Hcl | 28 | $305 |
| Methylprednisolone | 38 | $297 |
| Meloxicam | 66 | $260 |
| Fentanyl | 14 | $217 |
| Ketorolac Tromethamine | 13 | $156 |
| Ondansetron Hcl | 18 | $148 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Oklahoma City
- Paul JacobOklahoma City$822K
- Corey PonderOklahoma City$291K
- Kyle McGivernOklahoma City$19K
- Rishi ThakralOklahoma City$9K
- John TompkinsOklahoma City$450
- Scott DunitzTulsa$186K
- Zackary BurrowTulsa$17K
- James SlaterTulsa$7K
- Ronald LabuttiTulsa$6K
- Christian LuessenhopTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.